Medical Properties Trust (MPT) Cash & Equivalents (2009 - 2026)

Medical Properties Trust (MPT) has 18 years of Cash & Equivalents data on file, last reported at $425.0 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $425.0 million, down 36.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $425.0 million (down 36.89% YoY), and the FY2025 annual result was $540.9 million, up 62.75% from the prior year.
• Cash & Equivalents fell to $425.0 million in Q1 2026 per MPT's latest filing, from $540.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $673.5 million in Q1 2025 and troughed at $224.3 million in Q1 2024.
• A 5-year average of $367.2 million and a median of $324.0 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents plunged 66.68% in 2022, then jumped 200.21% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $235.7 million in 2022, then gained by 6.09% to $250.0 million in 2023, then jumped by 32.93% to $332.3 million in 2024, then surged by 62.75% to $540.9 million in 2025, then slipped by 21.42% to $425.0 million in 2026.
• Business Quant data shows MPT's Cash & Equivalents at $425.0 million in Q1 2026, $540.9 million in Q4 2025, and $396.6 million in Q3 2025.